Join us for an industry session and learn more about the Future of Precision Medicine: Advancements in Nanoscale Genomics
Explore the latest breakthroughs in pharmacogenomics and personalized medicine in this industry session. Don’t miss the opportunity to hear from leading experts in the field as they discuss transformative advancements in genomics technology and its implications for mental health treatment.
Industry Education Sessions | Room 108
Thursday, November 7 | 3:00 – 4:00 pm
This industry education session will focus on cutting-edge advancements in pharmacogenomics (PGx), emphasizing the utilization of nanoscale genomics to achieve comprehensive coverage of Association for Molecular Pathology (AMP) Tier 1 targets across a range of therapeutic areas.
Dr. Katherine Aitchison
Professor, Departments of Psychiatry & Medical Genetics, College of Health Sciences,
University of Alberta
Katherine Aitchison, BM BCh, PhD, FRCPsych, Professor (Departments of Psychiatry & Medical Genetics, College of Health Sciences, University of Alberta), will present preliminary results from a beta testing site, including target coverage implications for neuropsychiatric disorders.
Dr. Naveen Ramalingam
Senior Director of Microfluidics and Genomics Development, Standard BioTools
Naveen Ramalingam, PhD, Senior Director of R&D at Standard BioTools, will present on the revolutionary application of nanofluidic qPCR technology.
Contact us to learn more.
For Research Use Only. Not for use in diagnostic procedures. Patent and License Information: www.standardbio.com/legal/notices. Trademarks: www.standardbio.com/legal/trademarks. Any other trademarks are the sole property of their respective owners. ©2025 Standard BioTools Inc. All rights reserved.